Albro, P.W., Corbett, J.T., Schroeder, J.L., Jordan, S. and Matthews, H.B. (1982). Pharmacokinetics, interactions with macromolecules and species differences in metabolism of DEHP. Env. Health Persp. 45:19-25.
2.
Barber, J. and Jackson, S.J. (1982). Bis(2-ethylhexyl) phthalate: A Subacute Intraperitoneal Toxicity Study in the Marmoset. Report No. CTL/R/644. Prepared for CEFIC (European Council of the Federation of the Chemical Industry).
3.
Berge, R.K. and Bakke, O.M. (1981). Changes in lipid metabolizing enzymes of hepatic subcellular fractions from rats treated with tradenol and clofibrate. Biochem. Pharmacol. 30:2251-2256.
4.
Blane, G.F. and Pinaroli, F. (1980). Fenofibrate: Animal toxicology in relation to side-effects in man. Nouv. Presse Med. 9:3737-3746 (French).
5.
Bronfman, M., Inestrosa, N.C. and Leighton, F. (1979). Fatty acid oxidation by human liver peroxisomes . Biochem. Biophys. Res. Commun. 88:1030-1036.
6.
Christiansen, E.N., Flatmark, T. and Kryvi, H. (1981). Effects of marine oil diet on peroxisomes and mitochondria of rat liver: A combined biochemical and morphometric study. Eur. J. Cell Biol. 26:11-20.
7.
Cohen, A.J. and Grasso, P. (1981). Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man. Food Cosmet. Toxicol. 19:585-605.
8.
De La Iglesia, F.A., Pinn, S.M., Lucas,J. and Mc Guire, E.J. (1981). Quantitative stereology of peroxisomes in hepatocytes from hyperlipoproteinemic patients receiving gemfibrozil. Micron12:97-98.
9.
De La Iglesia, F.A., Lewis, J.E., Buchanan, R.A., Marcus, E.L. and Mc Mahon, G. (1982). Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment. Atherosclerosis43:19-37.
10.
Eacho, P.I., Foxworthy, P.S., Johnson, W.D. and Hoover, D.M. (1985). Induction of hepatomegaly associated with peroxisome proliferation by an alkoxytetrazoylacetophenone. Toxicologist5:158.
11.
Elcombe, C.R., Pratt, I.S. and Green, T. (1982). The rate of trichloroacetic acid formation determines the species difference in hepatic peroxisome proliferation due to trichloroethylene . Pharmacologist24:173.
12.
Fringes, B. and Rieth, A. (1982). Time course of peroxisome biogenesis during adaptation to mild hyperthyroidism in rat liver. Lab. Invest. 47:19-26.
13.
Ganning, A.E. and Dallner, G. (1981). Induction of peroxisomes and mitochondria by di(2-ethylhexyl)phthalate . FEBS Lett. 130:77-79.
14.
Ganning, A.E., Brunk, U. and Dallner, G. (1984). Phthalate esters and their effect on the liver . Hepatology4:541-547.
15.
Gariot, P., Barrat, E., Mejean, L., Pointel, J.P., Drouin, P. and Debry, G. (1983). Fenofibrate and human liver: Lack of proliferation of peroxisomes. Arch. Toxicol. 53:151-163.
16.
Gray, R.H. and De La Iglesia, F.A. (1984). Quantitative microscopy comparison of peroxisome proliferation by the lipid-regulating agent gemfibrozil in several species . Hepatology4:520-530.
17.
Gray, T.J.B., Lake, B.G., Beamand, J.A., Foster, J.R. and Gangolli, S.D. (1984). Species difference in response of primary hepatocyte cultures to peroxisome proliferation. (Abstract). Presented at Conference on Phthalic Acid Esters, August 6-7, 1984, Guildford, England.
18.
Hanefeld, M., Kemmer, C., Leonhardt, W., Kunze, K.O., Jaross, W. and Haller, H. (1980). Effects of p-chlorophenoxy-isobutyric acid (CPIB) on the human liver. Atherosclerosis36:159-172.
19.
Hanefeld, M., Kemmer, C. and Kadner, E. (1983). Relationship between morphological changes and lipid-lowering action of p-chlorphenoxy-isobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man. Atherosclerosis46:239-246.
20.
Harrison, R.D. (1983). Effects of the anabolic steroid trenbolone acetate, implanted alone or in combination with oestradiol-17 on liver cell ultrastructure in steers. Res. Vet. Sci. 34:21-23.
21.
Hess, R., Staubli, W. and Riess, W. (1965). Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature208:856-858.
22.
Holloway, B.R., Bentley, M. and Thorp, J.M. (1982). Species differences in the effects of ICI 55,897 on plasma lipids and hepatic peroxisomes. Ann. N.Y. Acad. Sci. 386:439-442.
23.
Hsieh, N. and Tolbert, N.E. (1976). Glyoxylate aminotransferase in peroxisomes from rat liver and kidney. J. Biol. Chem. 251:4408-4415.
24.
Ishii, H. and Suga, T. (1979). Clofibrate-like effects of acetylsalicydic acid on peroxisomes and on hepatic and serum triglyceride levels. Biochem. Pharmacol. 28:2829-2833.
25.
Ishii, H., Fukumori, N., Horie, S. and Suga, T. (1980). Effects of fat content in the diet on hepatic peroxisomes of the rat. Biochim. Biophys. Acta617:1-11.
26.
Katoh, H., Nakajima, S., Kawashima, Y., Kozuka, H. and Uchiyama, M. (1984). Induction of rat hepatic long-chain acyl-CoA hydrolases by various peroxisome proliferators. Biochem. Pharmacol. 33:1081-1085.
27.
Kawashima, Y., Tachibana, Y., Nakagawa, S. and Kozuka, H. (1984). Species difference of liver cytosolic fatty acid-binding protein in rat, mouse and guinea pig. Lipids19:481-487.
28.
Kurtz, S.M., Fitzgerald, J.E., Fisken, R.A., Schardein, J.L., Reutner, T.H. and Lacus, J.A. (1976). Toxicological studies on gemfibrozil. Proc. R. Soc. Med: 69(suppl.2):15-23.
29.
Lake, B.G., Gray, T.J.B., Foster, J.R., Stubberfield, C.R. and Gangolli, S.D. (1983). Species difference in di(2-ethylhexyl)phthalate induced hepatic peroxisome proliferation. Dev. Toxicol. Env. Sci. 11:595-598.
30.
Lake, B.G., Gray, T.J.B., Foster, J.R., Stubberfield, C.R. and Gangolli, S.C. (1984a). Comparative studies on di(2-ethylhexyl)phthalate-induced hepatic peroxisome proliferation in the rat and hamster. Toxicol. Appl. Pharmacol. 72:46-60.
31.
Lake, B.G., Rijcken, R.P., Gray, T.J.B., Foster, J.R. and Gangolli, S.D. (1984b). Comparative studies of the hepatic effects of di- and mono-n-octyl phthalates, di(2-ethylhexyl)phthalate and clofibrate in the rat. Acta Pharmacol. Toxicol. 54:167-176.
32.
Lalwani, N.D., Reddy, M.K., Qureshi, S.A., Sirtori, C.R., Abiko, Y. and Reddy, J.K. (1983a). Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver. Human Toxicol. 2:27-48.
33.
Lalwani, N.D., Reddy, M.K., Qureshi, S.A., Moehle, C.M. and Reddy, J.K. (1983b). Noninhibitory effect of antioxidants ethoxyquin, 2(3)-tert-butyl-4-hydroxyanisole and 3,5-di-tert-butyl-4-hydroxytoluene on hepatic peroxisome proliferation and peroxisome fatty acid β-oxidation induced by a hypolipidemic agent in rats. Cancer Res. 43:1680-1687.
34.
Lazarow, P.B. (1977). Three hypolipidemic drugs increase hepatic palmitoyl-coenzyme A oxidation in the rat. Science197:580-581.
35.
Lazarow, P.B. and De Duve, C. (1976). A fatty acyl-CoA oxidizing system in rat liver peroxisomes: Enhancement by clofibrate, a hypolipidemic drug. Proc. Nat. Acad. Sci. USA73:2043-2046.
36.
Lazarow, P.B., Shio, H. and Leroy-Houyet, M.A. (1982). Specificity in action of hypolipidemic drugs: Increase of peroxisomal β-oxidation largely dissociated from hepatomegaly and peroxisome proliferation in the rat. J. Lipid Res. 23:317-326.
37.
Markwell, M.K., Mc Groarty, E.J., Bieber, L.L. and Tolbert, N.E. (1973). The subcellular distribution of carnitine acyltransferases in mammalian liver and kidney. J. Biol. Chem. 248:3426-3432.
38.
Masters, C. and Holmes, R. (1977). Peroxisomes: New aspects of cell physiology and biochemistry. Physiol. Rev. 57:816-882.
39.
Mitchell, A.M., Bridges, J.W. and Elcombe, C.R. (1984). Factors influencing peroxisome proliferation in cultured rat hepatocytes. Arch. Toxicol. 55:239-246.
40.
Mitchell, A.M., Joseph, K. and Elcombe, C.R. (1985). Species difference in hepatic peroxisome proliferation . Hum. Toxicol. 4:552.
41.
Moody, D.E. and Reddy, J.K. (1977). Absence of increased carnitine acetyltransferase activity in the liver with proliferation of smooth endoplasmic reticulum. Biochem. Toxicol. 26:1451-1452.
42.
Moody, D.E. and Reddy, J.K. (1978a). The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid and Wy-14,643) on peroxisomes and peroxisome-associated enzymes. Am. J. Pathol. 90:435-446.
43.
Moody, D.E. and Reddy, J.K. (1978b). Hepatic peroxisome (microbody) proliferation in rats fed plasticizers and related compounds. Toxicol. Appl. Pharmacol. 45:497-504.
44.
National Institute For Occupational Safety And Health (Niosh). (1980). Registry of Toxic Effects of Chemical Substances. DHHS (NIOSH) Publ. No. 80-111.
45.
Nixon,J. and Jackson, S.J. (1982). Bis(2-ethylhexyl)phthalate: A Comparative Subacute Toxicity Study in the Rat and Marmoset. Report No. CTL/P/690. Prepared for CEFIC (European Council of the Federation of the Chemical Industry) .
46.
Noguchi, T. and Takada, Y. (1979). Peroxisomal location of alanine glyoxylate aminotransferase in human liver. Arch. Biochem. Biophys. 196:645-647.
47.
Orton, T.C., Adam, H.K., Bentley, M., Holloway, B. and Tucker, M.J. (1984). Clobuzarit: Species differences in the morphological and biochemical response of the liver following chronic administration. Toxicol. Appl. Pharmacol. 73:138-151.
48.
Osumi, T. and Hashimoto, T. (1978). Enhancement of fatty acyl-CoA oxidizing activity in rat liver peroxisomes by di(2-ethylhexyl)phthalate. J. Biochem. 83:1361-1365.
49.
Osumi, T. and Hashimoto, T. (1979). Subcellular distribution of the enzymes of the fatty acyl-CoA β-oxidation system and their induction by di(2-ethylhexyl)phthalate in rat liver. J. Biochem. 85:131-139.
50.
Pourbaix, S., Heller, F. and Harvengt, C. (1984). Effect of fenofibrate and LF 2151 on hepatic peroxisomes in hamsters. Biochem. Pharmacol. 33:3661-3666.
51.
Reddy, J.K., Moody, D.E., Azarnoff, D.L. and Rao, M.S. (1976). Di(2-ethylhexyl)phthalate : An industrial plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine acetyltransferase activities in rats and mice. Life Sci. 18:941-946.
52.
Reddy, J.K., Warren, J.R., Reddy, M.K. and Lalwani, N.D. (1982a). Hepatic and renal effects of peroxisome proliferators . Ann. NY Acad. Sci. 386:81-110.
53.
Reddy,J.K., Lalwani, N.D., Qureshi, S.A. and Reddy,J.K. (1982b). Induction of hamster hepatic peroxisomal β-oxidation and peroxisome proliferation-associated 80,000 mol. wt. polypeptide by hypolipidemic drugs. Human Toxicol. 1:135-147.
54.
Reddy, J.K., Lalwani, M.D., Qureshi, S.A., Reddy, M.K. and Moehle, C.M. (1984). Induction of hepatic peroxisome proliferation in nonrodent species, including primates. Am. J. Pathol. 114:171-183.
55.
Svoboda, D., Grady, H. and Azarnoff, D. (1967). Microbodies in experimentally altered cells. J. Cell Biol. 35:127-152.
56.
Thorp, J.M. (1982). β-oxidation/hypolipidemic drugs: General discussion . Ann. N.Y. Acad. Sci. 386:136.
57.
Turnbull, D. and Rodricks, J.V. (1985). Assessment of possible carcinogenic risk to humans resulting from exposure to di(2-ethylhexyl)phthalate(DEHP). J. Amer. Coll. Toxicol. 4:111-145.
58.
Van Veldhoven, P., De Clercq, P.E., Debeer, L.J. and Mannaerts, G.P. (1984). Effects of benfluorex and fenofibrate treatment on mitochondrial and peroxisomal marker enzymes in rat liver. Biochem. Pharmacol. 33:1153-1155.
59.
Watanabe, T. and Suga, T. (1983). Effects of phytol, a branched, long-chain aliphatic alcohol, on biochemical values and on hepatic peroxisomal enzymes of rats . Chem. Pharm. Bull. 31:2756-2761.
60.
Watanabe, T., Manna, H. and Suga, T. (1981). Effects of some hypolipidemic drugs on biochemical values and on hepatic peroxisomal enzymes of normolipidemic rat. J. Pharm. Dyn. 4:743-750.
